524723 Stock Overview
Bijoy Hans Limited engages in the trading of bulk drugs, pharmaceuticals, and cosmetics in India.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Bijoy Hans Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹23.00 |
52 Week High | ₹24.25 |
52 Week Low | ₹20.50 |
Beta | 0 |
1 Month Change | -4.92% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | 9.26% |
5 Year Change | n/a |
Change since IPO | 9.26% |
Recent News & Updates
Recent updates
Shareholder Returns
524723 | IN Healthcare | IN Market | |
---|---|---|---|
7D | 0% | -0.9% | 1.2% |
1Y | n/a | 59.9% | 45.3% |
Return vs Industry: Insufficient data to determine how 524723 performed against the Indian Healthcare industry.
Return vs Market: Insufficient data to determine how 524723 performed against the Indian Market.
Price Volatility
524723 volatility | |
---|---|
524723 Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.4% |
Market Average Movement | 6.7% |
10% most volatile stocks in IN Market | 10.0% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524723 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 524723's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | n/a | Ashok Patawari | www.bijoyhans.net |
Bijoy Hans Limited engages in the trading of bulk drugs, pharmaceuticals, and cosmetics in India. It offers various pharmaceutical formulations, including tablets, capsules, syrups, suspension, and powders focusing on various segments, such as antibiotics, cough/cold/allergy, H-1receptor antagonist (antiulcerant), nutraceuticals, and NSAIDS. The company is also involved in the investment activities.
Bijoy Hans Limited Fundamentals Summary
524723 fundamental statistics | |
---|---|
Market cap | ₹69.00m |
Earnings (TTM) | ₹0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 524723 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524723 income statement (TTM) | |
---|---|
Revenue | ₹0 |
Cost of Revenue | ₹0 |
Gross Profit | ₹0 |
Other Expenses | ₹0 |
Earnings | ₹0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 524723 perform over the long term?
See historical performance and comparison